Apriso and Itching - a phase IV clinical study of FDA data
Summary:
Itching is found among people who take Apriso, especially for people who are female, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Apriso and have Itching. It is created by eHealthMe based on reports of 3,141 people who have side effects when taking Apriso from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
3,141 people reported to have side effects when taking Apriso.
Among them, 65 people (2.07%) have Itching.
What is Apriso?
Apriso has active ingredients of mesalamine. It is often used in ulcerative colitis. eHealthMe is studying from 3,271 Apriso users for its effectiveness, alternative drugs and more.
What is Itching?
Itching is found to be associated with 4,468 drugs and 4,365 conditions by eHealthMe.
Number of Apriso and Itching reports submitted per year:
Time on Apriso when people have Itching *:
Gender of people who have Itching when taking Apriso*:
Age of people who have Itching when taking Apriso *:
Common drugs people take besides Apriso *:
Common side effects people have besides Itching *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Apriso and have Itching?
Check whether Itching is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Jacobsson H, Eriksen J, Karlén P, "Mesalazine-induced renal calculi", The American journal of case reports, 2015 Jan .
Related studies
How severe was Itching and when was it recovered:
Expand to all the drugs that have ingredients of mesalamine:
- Itching and drugs with ingredients of mesalamine (1,280 reports)
Alternative drugs to, pros and cons of Apriso:
- Apriso (3,271 reports)
Common Apriso side effects:
- Diarrhea: 318 reports
- Drug ineffective: 284 reports
- Ulcerative colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 236 reports
- Fatigue (feeling of tiredness): 203 reports
- Crohn's disease (condition that causes inflammation of the gastrointestinal tract): 159 reports
- Headache (pain in head): 150 reports
- Abdominal pain: 144 reports
Browse all side effects of Apriso:
a b c d e f g h i j k l m n o p q r s t u v w x y zItching treatments and more:
- Itching (330,813 reports)
COVID vaccines that are related to Itching:
- Itching in Moderna COVID Vaccine
- Itching in Pfizer BioNTech Covid Vaccine
- Itching in Johnson and Johnson Covid Vaccine
Common drugs associated with Itching:
- Prednisone: 14,612 reports
- Aspirin: 12,993 reports
- Humira: 12,525 reports
- Methotrexate: 11,960 reports
- Enbrel: 11,906 reports
- Dupixent: 11,478 reports
- Adapalene: 11,476 reports
- Metformin: 7,611 reports
- Cosentyx: 7,536 reports
- Omeprazole: 7,534 reports
All the drugs that are associated with Itching:
- Itching (4,468 drugs)
Common conditions associated with Itching:
- Rheumatoid arthritis: 16,747 reports
- Psoriasis: 12,849 reports
- Multiple sclerosis: 12,545 reports
- High blood pressure: 11,848 reports
- High blood cholesterol: 9,972 reports
- Acne: 7,656 reports
All the conditions that are associated with Itching:
- Itching (4,365 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on mesalamine (the active ingredients of Apriso) and Apriso (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Epirubicin Hydrochloride and Fluorouracil drug interaction - 6 seconds ago
- Symmetrel and Ards (Acute Respiratory Distress Syndrome) - 21 seconds ago
- Amlodipine and Cold Agglutinins Positive - 46 seconds ago
- Neupogen and Skin Swelling - a minute ago
- Clopra and Metastases To Brain - a minute ago
- Acetaminophen vs. Bentyl - a minute ago
- Colistimethate and Oramorph Sr drug interaction - a minute ago
- Linezolid and Weight Gain Poor - a minute ago
- Actigall and Myalgia Aggravated - a minute ago
- Burning Feet Syndrome in Gabapentin, how severe and when it was recovered? - a minute ago